Forward Looking Statement

Warning Concerning Forward-Looking Statements

Forward-looking statements can be identified by, among other things, the use of forward-looking language, such as “anticipate”, “believe”, “could”, “estimate”, “expect”, “future”, “intend”, “plan”, “potential”, and may describe opinions about future events. These forward-looking statements are based on the current expectations of the management of Oravax only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements. For example, we are using forward-looking statements when we discuss the development and potential efficacy of an oral COVID-19 vaccine, the ability of an oral COVID-19 vaccine to help quickly vaccinate portions of the population and expected results of any studies or trials and use and administration of an oral COVID-19 vaccine. In addition, historic results of scientific research and pre-clinical or clinical trials do not guarantee that the conclusions of future research or trials will suggest identical or even similar conclusions. In addition, the following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: Delays or obstacles in launching our clinical trials; inability to timely develop and introduce new technologies, products and applications; lack of validation of our technology as we progress further; unforeseen scientific difficulties that may develop with our process; greater cost of final product than anticipated; laboratory results that do not translate to equally good results in real settings; and finally that products may harm recipients, all of which could cause the actual results or performance of Oravax to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, Oravax undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.